NR3C1 and breast cancer: GR has also been shown to be a inducer of EMT in breast cancer cells (Shi et al., 2019), and overexpression of the homeobox protein HOX-A13 (HOXA13) in renal tubular epithelial cells can inhibit EMT by activating GR signaling (Peng et al., 2016).